Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.
Afqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration ...
Future Market Insights (FMI) has released a compelling projection indicating a significant surge in the global chromatography ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback